Financing › Details

Calliditas Therapeutics–SEVERAL: investment, 202005–202007 US IPO $81m+$6.9m with w 8.3m+707k common shares as ADSs at Nasdaq Global Market

	Period	2020-05-14 � 2020-07-02
	Region	United States (USA)
	Money taker	Calliditas Therapeutics AB (Nasdaq Stockholm: CALTX)
	Group	Asahi Kasei (Group)
	Money source	SEVERAL
	Product	Nefecon®
	Product 2	investment banking
	Index term	Calliditas Therapeutics–SEVERAL: investment, 202005–202006 private placement SEK82.9m with 924k common shares at SEK89.7/share outside US
	Source	Calliditas Therapeutics AB. (7/2/20). "Press Release: Exercise of Over-allotment Option and End of the Stabilization Period".

Record changed: 2021-01-14

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Asahi Kasei (Group)

[1] Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company"....
[2] Asahi Kasei Bioprocess. (4/11/24). "Press Release: Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development". Düsseldorf, Tokyo & New York, NY....
[3] VectivBio Holding AG. (3/13/23). "Press Release: VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan". Basel....
[4] VectivBio Holding AG. (3/30/22). "Press Release: VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts". Basel....
[5] Memo Therapeutics AG. (7/6/21). "Press Release: Memo Therapeutics AG Appoints Seasoned Executives Elias Papatheodorou as Chairman and Dr. Thomas Taapken as Member to Board of Directors". Schlieren....
[6] Calliditas Therapeutics AB. (8/25/20). "Press Release: Calliditas Appoints Group General Counsel"....
[7] Calliditas Therapeutics AB. (8/13/20). "Press Release: Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA"....
[8] Calliditas Therapeutics AB. (7/24/20). "Press Release: Calliditas Reorganizes Its Management Team"....
[9] Calliditas Therapeutics AB. (7/2/20). "Press Release: Exercise of Over-allotment Option and End of the Stabilization Period"....
[10] Calliditas Therapeutics AB. (6/5/20). "Press Release: Calliditas Therapeutics Prices Its Initial Public Offering on The Nasdaq Global Select Market in the United States"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]